Loading...
| A03195 | Pages: NA | Dec 2021 | 5189 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Gastrointestinal Therapeutics Market
Request Now !Gastrointestinal disorders are medical conditions related to the digestive system that affect the colon, small & large intestine, and rectum. The disorders mainly include constipation, peptic ulcer diseases, and irritable bowel syndrome characterized by various symptoms such as pain, bloating, diarrhea, nausea, and vomiting. Gastrointestinal therapeutics includes drugs, which are commercially available in the market namely Aciphex, Afinitor, Akynzeo, Dificid, and Prilosec.
The major factors that contribute to the growth of the gastrointestinal therapeutics market include the increasing prevalence of gastrointestinal diseases due to unhealthy dietary habits, additional numbers of clinical trials with accurate results, increasing healthcare expenditure, and growth in the geriatric population. However, side effects associated with the drugs and stringent governmental regulations for the approval of drugs are expected to restrain the market development. Rising demand for self-medication & regenerative medicines, along with a number of patient assistance programs carried out in emerging countries will contribute to a significant demand for gastrointestinal therapeutics in the near future.
The global gastrointestinal therapeutics market is segmented on the basis of type, application, dosage form, end-user, and region. On the basis of type, the market is segmented into prescription based gastrointestinal therapeutics and OTC gastrointestinal therapeutics. Based on application, the market is segmented into gastroenteritis, gastrointestinal bleeding, irritable bowel syndrome, peptic ulcer disease, and others. According to dosage form, the market is bifurcated into oral and injections. On the basis of end user, the market is segmented into hospitals, clinics, and others. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players that operate in this market include Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, Takeda Pharmaceutical Company Limited, AstraZeneca, Astellas Pharma US, Inc., and Pfizer Inc.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 GASTROINTESTINAL THERAPEUTICS MARKET, BY PRODUCT
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PRESCRIPTION BASED GASTROINTESTINAL THERAPEUTICS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. OTC GASTROINTESTINAL THERAPEUTICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 GASTROINTESTINAL THERAPEUTICS MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. GASTROENTERITIS
5.2.1. Market size and forecast
5.3. GASTROINTESTINAL BLEEDING
5.3.1. Market size and forecast
5.4. IRRITABLE BOWEL SYNDROME
5.4.1. Market size and forecast
5.5. PEPTIC ULCER DISEASE
5.5.1. Market size and forecast
5.6. OTHERS
5.6.1. Market size and forecast
CHAPTER 6 GASTROINTESTINAL THERAPEUTICS MARKET, BY DOASAGE FORM
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. ORAL
6.2.1. Market size and forecast
6.3. INJECTIONS
6.3.1. Market size and forecast
CHAPTER 7 GASTROINTESTINAL THERAPEUTICS MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. CLINICS
7.3.1. Market size and forecast
7.4. OTHERS
7.4.1. Market size and forecast
CHAPTER 8 GASTROINTESTINAL THERAPEUTICS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.2.4. North America Gastrointestinal Therapeutics Market by Product
8.2.5. North America Gastrointestinal Therapeutics Market by Application
8.2.6. North America Gastrointestinal Therapeutics Market by Doasage Form
8.2.7. North America Gastrointestinal Therapeutics Market by End User
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.3.4. Europe Gastrointestinal Therapeutics Market by Product
8.3.5. Europe Gastrointestinal Therapeutics Market by Application
8.3.6. Europe Gastrointestinal Therapeutics Market by Doasage Form
8.3.7. Europe Gastrointestinal Therapeutics Market by End User
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast
8.4.4. Asia-Pacific Gastrointestinal Therapeutics Market by Product
8.4.5. Asia-Pacific Gastrointestinal Therapeutics Market by Application
8.4.6. Asia-Pacific Gastrointestinal Therapeutics Market by Doasage Form
8.4.7. Asia-Pacific Gastrointestinal Therapeutics Market by End User
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
8.5.4. LAMEA Gastrointestinal Therapeutics Market by Product
8.5.5. LAMEA Gastrointestinal Therapeutics Market by Application
8.5.6. LAMEA Gastrointestinal Therapeutics Market by Doasage Form
8.5.7. LAMEA Gastrointestinal Therapeutics Market by End User
CHAPTER 9 COMPANY PROFILES
9.1. ABBOTT LABORATORIES
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. JOHNSON & JOHNSON
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. ABBVIE INC.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. SALIX PHARMACEUTICALS
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. GLAXOSMITHKLINE PLC.
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. ALLERGAN
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. TAKEDA PHARMACEUTICAL COMPANY LIMITED
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. ASTRAZENECA
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. ASTELLAS PHARMA US, INC.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. PFIZER INC.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
